We are thrilled to share that Ms. Jennifer Che, our President and Managing Director, has been recognized in IAM Strategy 300 Global Leaders 2026. This follows our recent announcement recognizing Ms. Che in the list of IAM Global Leaders 2026, which focuses on patent prosecution.

IAM Strategy 300 showcases the top strategy experts in the IP world. It is the “only resource of its kind, acknowledging leaders from across in-house, private practice and service provider roles”. A slot in the 300 is the “mark of a professional whose approach to intellectual property is regarded by peers as truly strategic in nature.”

IAM's comprehensive research process involved gathering nominations and insights from thousands of sources over a five month period, leading to in-depth interviews with selected candidates.

Jennifer's inclusion in this elite group is a testament to her ability to inspire and innovate, continually providing exceptional value to our clients and setting a benchmark in the industry.


Please join us in congratulating Jennifer on this well-deserved recognition. Her expertise and dedication to her work make her an invaluable asset to our team and our clients.

我们的过去活动

Recommended Insights

China’s Newest Examination Guidelines: Novelty and Inventive Step for Compounds (Part II)

2021年4月29日
This is Part II of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]

Beijing IP Court Reverses CNIPA Decision and Upholds Ozempic® semaglutide patent in China as VALID based on Novo Nordisk’s Post Filing Data

2024年6月27日
Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic® and Wegovy®, will expire on March 20, 2026. It goes without saying that generics are ramping up bigtime in China (and also around the world), preparing to manufacture and sell this blockbuster drug to one of the […]

Announcement: Implementation Regulations (Rules) of the Chinese Patent Law have been Approved

2023年11月10日
On November 3rd, 2023, the Premier of the State Council, Li Qiang, chaired a regular meeting where the "Implementation Regulations of the Patent Law of the People's Republic of China (Revised Draft)" was reviewed and approved. This is great news, as we have been waiting quite some time for these Regulations (Rules) to be approved (see […]

Why Do Examiners Fail to Recognize the Importance of my “Parameter Features”?

2025年5月28日
The Impact of Parameter Features on Inventiveness ”Parameter features” – numerical or mathematical expressions that define the quantity or physical properties of a subject – frequently appear as technical features within a claim. Often described as numerical ranges or measurements, they frequently play a critical role in addressing technical problems. However, in practice, Examiners and […]
Top crossarrow-right